Incheon, South Korea

Bong Joon Kim

USPTO Granted Patents = 11 


 

Average Co-Inventor Count = 6.9

ph-index = 3

Forward Citations = 17(Granted Patents)


Location History:

  • Seoul, KR (2022)
  • Incheon, KR (2017 - 2023)
  • Inchon, KR (2018 - 2023)

Company Filing History:


Years Active: 2017-2023

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Innovations of Bong Joon Kim

Introduction

Bong Joon Kim is a prominent inventor based in Incheon, South Korea. He has made significant contributions to the field of immunology and intestinal health through his innovative patents. With a total of 11 patents to his name, Kim's work focuses on developing compositions that address various health issues.

Latest Patents

Among his latest patents is a method for treating immune diseases caused by a Th1/Th2 imbalance. This method involves administering a composition comprising the CJLP133 strain KCTC 11403BP to subjects in need. Another notable patent includes a composition for treating intestinal diseases, which features CJLP243 (KCTC 11045P). Additionally, he has developed a composition aimed at enhancing immune response, also based on CJLP243.

Career Highlights

Bong Joon Kim is associated with Cj Cheiljedang Corporation, where he continues to innovate and contribute to advancements in health-related compositions. His work has garnered attention for its potential impact on treating immune and intestinal diseases.

Collaborations

He has collaborated with notable coworkers, including Heon Woong Jung and Kwang Woo Hwang, to further enhance the research and development of his innovative solutions.

Conclusion

Bong Joon Kim's contributions to the field of immunology and intestinal health through his patents reflect his dedication to improving health outcomes. His innovative approaches continue to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…